Pulmonary Embolism Symposium (PERT 2017)

 

Session 4: Anticoagulation
11:14

Pulmonary Embolism Symposium (PERT 2017)

Current Regulatory Environment and Potential FDA Role in Furthering the Goals of the PERT Consortium to Improve Outcomes for Patients with PE and VTE

  • 11 views
  • October 16, 2017
11:46

Pulmonary Embolism Symposium (PERT 2017)

DOACs and Other Heparin Alternatives

FEATURING Rachel Rosovsky
  • 710 views
  • October 16, 2017
  • 2
13:55

Pulmonary Embolism Symposium (PERT 2017)

NOAC Reversal Agents - Our Early Experience

FEATURING George Davis
  • 635 views
  • October 16, 2017
10:12

Pulmonary Embolism Symposium (PERT 2017)

Long Term Anticoagulation - How and For How Long?

  • 52 views
  • October 16, 2017
  • 1
10:05

Pulmonary Embolism Symposium (PERT 2017)

Panel Discussion - Q&A with the Experts from PERT 2017

  • 10 views
  • October 16, 2017